Collaborating with University of Rochester read our new paper out now in Cell Death & Disease by leader author Jeff Harder! Harder JM, Williams PA, Soto I, Foxworth NE, Fernandes KA, Freeburg NF, Howell GR, Libby R, John SWM. “Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice”. Cell Death & … Continue reading New paper in Cell Death & Disease
Collaborating with Kaiser Permanente, UCSF, and The Jackson Laboratory read our new paper out now in Nature Communications! Choquet H, Paylakhi S, Kneeland SC, Thai KK, Hoffmann TJ, Yin J, Kvale MN, Banda Y, Tolman NG, Williams PA, Schaefer C, Melles R, Risch N, John SWM, Nair KS, Jorgenson E. “A multiethnic genome-wide association study of … Continue reading New paper in Nature Communications
Read our new short report in Communicative & Integrative Biology! Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM. “Nicotinamide treatment robustly protects from inherited mouse glaucoma”. Communicative & Integrative Biology. 2018 (doi: 10.1080/19420889.2017.1356956) [pdf]
Read out new review out now in J Glaucoma. Williams PA, Harder JM, John SWM. “Glaucoma as a metabolic optic neuropathy: making the case for nicotinamide treatment in glaucoma”. Journal of Glaucoma. 2017 (doi: 10.1097/IJG.0000000000000767) [pdf]
Our recent paper in Science was featured in NEJM.
Read our newest manuscript in Frontiers in Neuroscience! Williams PA, Harder JM, Foxworth NE, Cardozo BH, John SWM. “Nicotinamide and WLDS act together to prevent neurodegeneration in glaucoma”. Frontiers in Neuroscience. 2017 (doi: 10.3389/fnins.2017.00232) [pdf]
Vitamin B3 protects mice from glaucoma [From Science] Glaucoma is the most common cause of age-related blindness in the United States. There is currently no cure, and once vision is lost, the condition is irreversible. Williams et al. now report that vitamin B3 (also known as niacin) prevents eye degeneration in glaucoma-prone mice (see the … Continue reading New manuscript in Science